Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients
Completed · Phase 2 · Has a placebo group
Conditions studied: HIV Infections
In brief
New treatment options are critical for treatment-experienced HIV infected patients with drug resistance. HIV entry inhibitors have been shown effective in patients with resistance to other anti-HIV drugs. This study will test the safety and effectiveness of three different doses of vicriviroc (formerly known as Schering D, SCH-D, or SCH 417690) in HIV infected patients.
Key facts
- Study ID
- NCT00082498
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 119
- Starts
- 2004-05-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2021-11-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA CARE Center CRS — Los Angeles, California, United States
- Stanford AIDS Clinical Trials Unit CRS — Palo Alto, California, United States
- UCSD Antiviral Research Center CRS — San Diego, California, United States
- Ucsf Hiv/Aids Crs — San Francisco, California, United States
- Santa Clara Valley Med. Ctr. — San Jose, California, United States
- University of Colorado Hospital CRS — Aurora, Colorado, United States
- Georgetown University CRS (GU CRS) — Washington D.C., District of Columbia, United States
- The Ponce de Leon Center CRS — Atlanta, Georgia, United States
- Rush University CRS — Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic — Indianapolis, Indiana, United States
- Massachusetts General Hospital CRS (MGH CRS) — Boston, Massachusetts, United States
- Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS — Boston, Massachusetts, United States
- Bmc Actg Crs — Boston, Massachusetts, United States
- Washington University Therapeutics (WT) CRS — St Louis, Missouri, United States
- Beth Israel Med. Ctr., ACTU — New York, New York, United States
- Weill Cornell Chelsea CRS — New York, New York, United States
- NY Univ. HIV/AIDS CRS — New York, New York, United States
- Weill Cornell Uptown CRS — New York, New York, United States
- Trillium Health ACTG CRS — Rochester, New York, United States
- Univ. of Rochester ACTG CRS — Rochester, New York, United States
- Chapel Hill CRS — Chapel Hill, North Carolina, United States
- Case CRS — Cleveland, Ohio, United States
- MetroHealth CRS — Cleveland, Ohio, United States
- Ohio State University CRS — Columbus, Ohio, United States
- Penn Therapeutics, CRS — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.